| 17alpha-ethynylestradiol | affects expression | ISO | RGD:732065 | 6480464 | Ethinyl Estradiol affects the expression of ABAT mRNA | CTD | PMID:20170705 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:732065 | 6480464 | Ethinyl Estradiol results in decreased expression of ABAT mRNA | CTD | PMID:18936297 |
| 17beta-estradiol | affects expression | ISO | RGD:732065 | 6480464 | Estradiol affects the expression of ABAT mRNA | CTD | PMID:14699072 |
| 17beta-estradiol | multiple interactions | ISO | RGD:732065 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of ABAT mRNA | CTD | PMID:17404688 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1332048 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ABAT mRNA | CTD | PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ABAT mRNA | CTD | PMID:20959002 PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ABAT mRNA | CTD | PMID:21215274 |
| 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of ABAT mRNA | CTD | PMID:21346803 |
| 3,4-methylenedioxymethamphetamine | increases expression | ISO | RGD:1332048 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in increased expression of ABAT mRNA | CTD | PMID:20188158 |
| 4,4'-diaminodiphenylmethane | decreases expression | ISO | RGD:1332048 | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of ABAT mRNA | CTD | PMID:18648102 |
| aflatoxin B1 | affects expression | ISO | RGD:732065 | 6480464 | Aflatoxin B1 affects the expression of ABAT protein | CTD | PMID:20106945 |
| aflatoxin B1 | decreases expression | ISO | RGD:732065 | 6480464 | Aflatoxin B1 results in decreased expression of ABAT mRNA | CTD | PMID:22100608 |
| aflatoxin B1 | decreases expression | ISO | RGD:1332048 | 6480464 | Aflatoxin B1 results in decreased expression of ABAT mRNA | CTD | PMID:19770486 |
| all-trans-retinoic acid | increases expression | ISO | RGD:732065 | 6480464 | Tretinoin results in increased expression of ABAT mRNA | CTD | PMID:21934132 |
| aluminium trichloride | decreases activity | EXP | | 6480464 | aluminum chloride results in decreased activity of ABAT protein | CTD | PMID:11696403 |
| amitriptyline | decreases expression | EXP | | 6480464 | Amitriptyline results in decreased expression of ABAT mRNA | CTD | PMID:21820738 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ABAT mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | decreases expression | ISO | RGD:732065 | 6480464 | Benzo(a)pyrene results in decreased expression of ABAT mRNA | CTD | PMID:20064835 PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:732065 | 6480464 | Benzo(a)pyrene results in decreased expression of ABAT mRNA | CTD | PMID:20064835 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:1332048 | 6480464 | Benzo(a)pyrene results in increased expression of ABAT mRNA | CTD | PMID:19770486 PMID:22228805 |
| benzo[a]pyrene | increases expression | ISO | RGD:1332048 | 6480464 | Benzo(a)pyrene results in increased expression of ABAT mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | decreases expression | ISO | RGD:732065 | 6480464 | Benzo(a)pyrene results in decreased expression of ABAT mRNA | CTD | PMID:20106945 PMID:20064835 |
| bisphenol A | affects expression | ISO | RGD:732065 | 6480464 | bisphenol A affects the expression of ABAT mRNA | CTD | PMID:20170705 |
| cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of ABAT promoter | CTD | PMID:22457795 |
| calcitriol | increases expression | ISO | RGD:732065 | 6480464 | Calcitriol results in increased expression of ABAT mRNA | CTD | PMID:16002434 |
| choline | multiple interactions | ISO | RGD:1332048 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ABAT mRNA | CTD | PMID:20938992 |
| clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of ABAT mRNA | CTD | PMID:12851107 |
| cocaine | increases response to substance | ISO | RGD:1332048 | 6480464 | ABAT mRNA results in increased susceptibility to Cocaine | CTD | PMID:10850552 |
| copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of ABAT mRNA | CTD | PMID:22465980 |
| copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of ABAT mRNA | CTD | PMID:22465980 |
| copper(2+) sulfate | increases expression | ISO | RGD:732065 | 6480464 | Copper Sulfate results in increased expression of ABAT mRNA | CTD | PMID:19549813 |
| coumestrol | increases expression | ISO | RGD:732065 | 6480464 | Coumestrol results in increased expression of ABAT mRNA | CTD | PMID:19167446 |
| cyclosporin A | decreases expression | ISO | RGD:732065 | 6480464 | Cyclosporine results in decreased expression of ABAT mRNA | CTD | PMID:20106945 |
| dibutyl phthalate | decreases expression | ISO | RGD:1332048 | 6480464 | Dibutyl Phthalate results in decreased expression of ABAT mRNA | CTD | PMID:21266533 |
| disulfiram | multiple interactions | EXP | | 6480464 | [Ethanol co-treated with Disulfiram] results in decreased activity of ABAT protein; more ... | CTD | PMID:9591243 |
| ethanol | multiple interactions | EXP | | 6480464 | [Ethanol co-treated with Disulfiram] results in decreased expression of ABAT mRNA; more ... | CTD | PMID:9591243 |
| folic acid | multiple interactions | ISO | RGD:1332048 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ABAT mRNA | CTD | PMID:20938992 |
| furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of ABAT gene | CTD | PMID:22079235 |
| gamma-aminobutyric acid | multiple interactions | ISO | RGD:732065 | 6480464 | [Vigabatrin results in decreased activity of ABAT protein] which results in increased abundance of gamma-Aminobutyric Acid | CTD | PMID:12748807 |
| gamma-aminobutyric acid | multiple interactions | EXP | | 6480464 | [Vigabatrin results in decreased activity of ABAT protein] which results in increased abundance of gamma-Aminobutyric Acid | CTD | PMID:11468302 |
| genistein | decreases expression | ISO | RGD:732065 | 6480464 | Genistein results in decreased expression of ABAT protein | CTD | PMID:20884965 |
| genistein | multiple interactions | ISO | RGD:732065 | 6480464 | ESR2 promotes the reaction [Genistein results in decreased expression of ABAT protein] | CTD | PMID:20884965 |
| L-methionine | multiple interactions | ISO | RGD:1332048 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of ABAT mRNA | CTD | PMID:20938992 |
| lithium chloride | decreases expression | ISO | RGD:732065 | 6480464 | Lithium Chloride results in decreased expression of ABAT mRNA | CTD | PMID:15711924 |
| methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of ABAT mRNA | CTD | PMID:16393664 |
| methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of ABAT mRNA | CTD | PMID:16393664 PMID:23274394 |
| ochratoxin A | decreases expression | EXP | | 6480464 | ochratoxin A results in decreased expression of ABAT mRNA | CTD | PMID:18417182 |
| paracetamol | affects expression | ISO | RGD:1332048 | 6480464 | Acetaminophen affects the expression of ABAT mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:1332048 | 6480464 | Acetaminophen results in increased expression of ABAT protein | CTD | PMID:21329376 |
| perfluorooctanoic acid | decreases expression | EXP | | 6480464 | perfluorooctanoic acid results in decreased expression of ABAT mRNA | CTD | PMID:19162173 |
| permethrin | affects activity | EXP | | 6480464 | Permethrin affects the activity of ABAT protein | CTD | PMID:15189238 |
| phlorizin | decreases expression | ISO | RGD:1332048 | 6480464 | Phlorhizin results in decreased expression of ABAT mRNA | CTD | PMID:22538082 |
| pirinixic acid | multiple interactions | ISO | RGD:732065 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ABAT mRNA | CTD | PMID:19710929 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of ABAT mRNA | CTD | PMID:19162173 PMID:17164430 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of ABAT mRNA | CTD | PMID:17164430 PMID:19162173 |
| pregnenolone 16alpha-carbonitrile | decreases expression | EXP | | 6480464 | Pregnenolone Carbonitrile results in decreased expression of ABAT mRNA | CTD | PMID:19162173 |
| progesterone | multiple interactions | ISO | RGD:732065 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of ABAT mRNA | CTD | PMID:17404688 |
| rosiglitazone | decreases expression | EXP | | 6480464 | rosiglitazone results in decreased expression of ABAT mRNA | CTD | PMID:21515302 |
| tetrachloromethane | increases expression | ISO | RGD:1332048 | 6480464 | Carbon Tetrachloride results in increased expression of ABAT mRNA | CTD | PMID:17484886 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of ABAT mRNA | CTD | PMID:21515302 |
| valproic acid | increases expression | ISO | RGD:732065 | 6480464 | Valproic Acid results in increased expression of ABAT mRNA | CTD | PMID:19101580 |
| vancomycin | increases expression | ISO | RGD:1332048 | 6480464 | Vancomycin results in increased expression of ABAT mRNA | CTD | PMID:18930951 |
| vigabatrin | decreases activity | ISO | RGD:732065 | 6480464 | Vigabatrin results in decreased activity of ABAT protein | CTD | PMID:12748807 |
| vigabatrin | multiple interactions | ISO | RGD:732065 | 6480464 | [Vigabatrin results in decreased activity of ABAT protein] which results in increased abundance of gamma-Aminobutyric Acid | CTD | PMID:12748807 |
| vigabatrin | multiple interactions | EXP | | 6480464 | [Vigabatrin results in decreased activity of ABAT protein] which results in increased abundance of gamma-Aminobutyric Acid | CTD | PMID:11468302 |
| vigabatrin | decreases activity | EXP | | 6480464 | Vigabatrin results in decreased activity of ABAT protein | CTD | PMID:11468302 PMID:3933514 |
| vigabatrin | decreases activity | ISO | RGD:732065 | 6480464 | Vigabatrin results in decreased activity of ABAT protein | CTD | PMID:10951220 PMID:12748807 |
| vigabatrin | decreases activity | EXP | | 6480464 | Vigabatrin results in decreased activity of ABAT protein | CTD | PMID:3933514 PMID:11468302 |
| vigabatrin | decreases activity | ISO | RGD:732065 | 6480464 | Vigabatrin results in decreased activity of ABAT protein | CTD | PMID:12748807 PMID:10951220 |